$ABUS I’m looking forward to bidding war for Arbutus BioPharma between $PFE $BNTX and $MRNA. After all, Arbutus hold the key patent they all want, has a robust pipeline with Hepatitis B candidates and Arbutus is very affordable for these 3 Pharma players.
  • 9
9 Likes